TotalMarketCap

Gelteq

GELSNasdaq AustraliaHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$4.880 M

$0.46 -1.19%

Close of 6 Nov 2026

As of 6 Nov 2026, Gelteq (GELS) has a market capitalization of $4.88M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #449Processa PharmaceuticalsPCSA$5.26M
  2. #450ScientureSCNX$5.18M
  3. #451GelteqGELS$4.88M
  4. #452ImunonIMNN$4.86M
  5. #453Addex TherapeuticsADXN$4.86M

What if Gelteq were worth as much as…

Open the what-if tool →

Gold $28.2T

$2,636,236

Per share 5,786,294× higher

Bitcoin $1.53T

$142,642.13

Per share 313,086× higher

Apple $5.02T

$468,280.78

Per share 1,027,833× higher

Or at a round number

$10.0M$20.0M$50.0M$100.0M

Where these numbers come from

Share counts and financials for Gelteq are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.